Icon

ESTRADERM (nda019081)- (0.05MG/24HR,0.1MG/24HR)

ESTRADIOL NOVARTIS
0.05MG/24HR,0.1MG/24HR
No No
2001-Feb-17 Expired
None None
None No
Estraderm is indicated in: 1. Treatment of moderate to severe vasomotor symptoms due to menopause. 2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. 3. Treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure. 4. Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medications should be carefully considered.
0 0 0
Total Other Developers None
Drugs with Suitability No
0.05MG/24HR ** ** - - -
0.1MG/24HR ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.